NASDAQ:SPNE - SeaSpine Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SeaSpine Holdings Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $13.06 +0.17 (+1.32 %) (As of 12/9/2019 01:14 AM ET) Add Compare Today's Range$12.83Now: $13.06▼$13.1950-Day Range$11.08MA: $12.85▼$14.0652-Week Range$10.44Now: $13.06▼$18.53Volume108,115 shsAverage Volume55,518 shsMarket Capitalization$249.05 millionP/E RatioN/ADividend YieldN/ABeta0.18 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SPNE Previous Symbol CUSIPN/A CIK1637761 Webhttp://www.seaspine.com/ Phone760-727-8399Debt Debt-to-Equity RatioN/A Current Ratio3.29 Quick Ratio1.75Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$143.44 million Price / Sales1.74 Cash FlowN/A Price / Cash FlowN/A Book Value$7.67 per share Price / Book1.70Profitability EPS (Most Recent Fiscal Year)($2.18) Net Income$-33,520,000.00 Net Margins-26.22% Return on Equity-27.36% Return on Assets-21.90%Miscellaneous Employees361 Outstanding Shares19,070,000Market Cap$249.05 million Next Earnings Date2/26/2020 (Estimated) OptionableOptionable Receive SPNE News and Ratings via Email Sign-up to receive the latest news and ratings for SPNE and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:SPNE Rates by TradingView SeaSpine (NASDAQ:SPNE) Frequently Asked Questions What is SeaSpine's stock symbol? SeaSpine trades on the NASDAQ under the ticker symbol "SPNE." How were SeaSpine's earnings last quarter? SeaSpine Holdings Corp (NASDAQ:SPNE) issued its earnings results on Tuesday, October, 29th. The medical equipment provider reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by $0.08. The medical equipment provider earned $39.89 million during the quarter, compared to the consensus estimate of $38.48 million. SeaSpine had a negative return on equity of 27.36% and a negative net margin of 26.22%. View SeaSpine's Earnings History. When is SeaSpine's next earnings date? SeaSpine is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for SeaSpine. What price target have analysts set for SPNE? 3 Wall Street analysts have issued 1-year target prices for SeaSpine's shares. Their forecasts range from $20.00 to $22.00. On average, they anticipate SeaSpine's share price to reach $21.33 in the next year. This suggests a possible upside of 63.3% from the stock's current price. View Analyst Price Targets for SeaSpine. What is the consensus analysts' recommendation for SeaSpine? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SeaSpine in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SeaSpine. What are Wall Street analysts saying about SeaSpine stock? Here are some recent quotes from research analysts about SeaSpine stock: 1. According to Zacks Investment Research, "SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company also offers orthobiologics and spinal fusion hardware solutions. SeaSpine Holdings Corporation is headquartered in Vista, California. " (11/2/2019) 2. Cantor Fitzgerald analysts commented, ": We reiterate our Overweight rating and $22 PT on SPNE. The strong execution that drove double-digit growth in 2H18 carried over into 2019 as SPNE posted 1Q revenue of $36MM (+9%), beating FactSet consensus by ~ $1MM, despite one less selling day, which we estimate likely created a 150bp headwind. SPNE is executing on its plan to add more exclusive distributors, increase proportion of revenue from recently launched products and progress against plan for staged launch of new products. SPNE raised the lower end of its 2019 sales guidance to $154-156MM (+7.5-9%), but we still consider guidance conservative and would not be surprised to see more beat and raises." (5/2/2019) 3. BTIG Research analysts commented, "We reiterate our Buy rating and $20 PT on SPNE following investor meetings in New York. High level takeaways from meetings noted an encouraging cadence of new product introductions in FY19 and beyond, a growing proportion of committed and exclusive distributors supporting SPNE’s portfolio, access to capital (without the need for additional funds in the next 3 years), achievable guidance, and an inexpensive valuation (absolute and relative). While 1Q is typically a seasonally softer quarter in spine, the outlook for FY19 is encouraging and if 2H18 is indicative of the momentum SPNE is seeing amongst its distributors and customers then a few more quarters of consistent execution should have shares re-rating at an improved multiple. We like SPNE’s set-up in FY19 as all the key pieces are in place for improved and continued momentum." (3/31/2019) Has SeaSpine been receiving favorable news coverage? Media coverage about SPNE stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. SeaSpine earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for SeaSpine. Are investors shorting SeaSpine? SeaSpine saw a drop in short interest in the month of October. As of October 15th, there was short interest totalling 134,800 shares, a drop of 6.1% from the September 15th total of 143,600 shares. Based on an average trading volume of 45,500 shares, the short-interest ratio is currently 3.0 days. Approximately 0.9% of the company's shares are short sold. View SeaSpine's Current Options Chain. Who are some of SeaSpine's key competitors? Some companies that are related to SeaSpine include Cryolife (CRY), Luminex (LMNX), Orthofix Medical (OFIX), MiMedx Group (MDXG), Anika Therapeutics (ANIK), Antares Pharma (ATRS), LeMaitre Vascular (LMAT), Axonics Modulation Technologies (AXNX), Intersect ENT (XENT), Orthopediatrics (KIDS), Cerus (CERS), AngioDynamics (ANGO), SurModics (SRDX), OraSure Technologies (OSUR) and SI-Bone (SIBN). What other stocks do shareholders of SeaSpine own? Based on aggregate information from My MarketBeat watchlists, some companies that other SeaSpine investors own include Madrigal Pharmaceuticals (MDGL), Athenex (ATNX), Exelixis (EXEL), Eyepoint Pharmaceuticals (EYPT), Global Blood Therapeutics (GBT), Galmed Pharmaceuticals (GLMD), Uniqure (QURE), Rigel Pharmaceuticals (RIGL), Viewray (VRAY) and Verastem (VSTM). Who are SeaSpine's key executives? SeaSpine's management team includes the folowing people: Mr. Keith C. Valentine, Pres, CEO & Director (Age 51)Mr. John J. Bostjancic, Sr. VP, CFO & Treasurer (Age 48)Mr. Patrick L. Keran, VP, Gen. Counsel & Corp. Sec. (Age 47)Carrie Mendivil, Head of Investor RelationsMr. John J. Winge, VP of Sales (Age 52) Who are SeaSpine's major shareholders? SeaSpine's stock is owned by a number of of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (4.16%), State Street Corp (1.43%), Boston Partners (0.66%), Mackay Shields LLC (0.55%), Essex Investment Management Co. LLC (0.54%) and Squarepoint Ops LLC (0.47%). Company insiders that own SeaSpine stock include John B Henneman III, Keith Bradley, Richard E Caruso and Stuart Essig. View Institutional Ownership Trends for SeaSpine. Which institutional investors are selling SeaSpine stock? SPNE stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Russell Investments Group Ltd., Mackay Shields LLC, Squarepoint Ops LLC, Essex Investment Management Co. LLC, California Public Employees Retirement System and Assenagon Asset Management S.A.. Company insiders that have sold SeaSpine company stock in the last year include Richard E Caruso and Stuart Essig. View Insider Buying and Selling for SeaSpine. Which institutional investors are buying SeaSpine stock? SPNE stock was acquired by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, Boston Partners, Commonwealth Equity Services LLC, Rhumbline Advisers and State Street Corp. View Insider Buying and Selling for SeaSpine. How do I buy shares of SeaSpine? Shares of SPNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is SeaSpine's stock price today? One share of SPNE stock can currently be purchased for approximately $13.06. How big of a company is SeaSpine? SeaSpine has a market capitalization of $249.05 million and generates $143.44 million in revenue each year. The medical equipment provider earns $-33,520,000.00 in net income (profit) each year or ($2.18) on an earnings per share basis. SeaSpine employs 361 workers across the globe.View Additional Information About SeaSpine. What is SeaSpine's official website? The official website for SeaSpine is http://www.seaspine.com/. How can I contact SeaSpine? SeaSpine's mailing address is 5770 ARMADA DRIVE, CARLSBAD CA, 92008. The medical equipment provider can be reached via phone at 760-727-8399 or via email at [email protected] MarketBeat Community Rating for SeaSpine (NASDAQ SPNE)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 194 (Vote Outperform)Underperform Votes: 150 (Vote Underperform)Total Votes: 344MarketBeat's community ratings are surveys of what our community members think about SeaSpine and other stocks. Vote "Outperform" if you believe SPNE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SPNE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2019 by MarketBeat.com StaffFeatured Article: Should You Consider an Index Fund?
